185 related articles for article (PubMed ID: 16373658)
1. Clinical implication of centrosome amplification in plasma cell neoplasm.
Chng WJ; Ahmann GJ; Henderson K; Santana-Davila R; Greipp PR; Gertz MA; Lacy MQ; Dispenzieri A; Kumar S; Rajkumar SV; Lust JA; Kyle RA; Zeldenrust SR; Hayman SR; Fonseca R
Blood; 2006 May; 107(9):3669-75. PubMed ID: 16373658
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma.
Dementyeva E; Kryukov F; Kubiczkova L; Nemec P; Sevcikova S; Ihnatova I; Jarkovsky J; Minarik J; Stefanikova Z; Kuglik P; Hajek R
J Transl Med; 2013 Mar; 11():77. PubMed ID: 23522059
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
4. Centrosome amplification drives chromosomal instability in breast tumor development.
Lingle WL; Barrett SL; Negron VC; D'Assoro AB; Boeneman K; Liu W; Whitehead CM; Reynolds C; Salisbury JL
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1978-83. PubMed ID: 11830638
[TBL] [Abstract][Full Text] [Related]
5. Centrosomes and myeloma; aneuploidy and proliferation.
Chng WJ; Fonseca R
Environ Mol Mutagen; 2009 Oct; 50(8):697-707. PubMed ID: 19739237
[TBL] [Abstract][Full Text] [Related]
6. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
[TBL] [Abstract][Full Text] [Related]
7. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
9. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
10. Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.
Hanamura I; Stewart JP; Huang Y; Zhan F; Santra M; Sawyer JR; Hollmig K; Zangarri M; Pineda-Roman M; van Rhee F; Cavallo F; Burington B; Crowley J; Tricot G; Barlogie B; Shaughnessy JD
Blood; 2006 Sep; 108(5):1724-32. PubMed ID: 16705089
[TBL] [Abstract][Full Text] [Related]
11. Visualization of numerical centrosomal abnormalities by immunofluorescent staining.
Kryukov F; Dementyeva E; Kuglík P; Hájek R
Klin Onkol; 2011; 24 Suppl():S49-52. PubMed ID: 21923065
[TBL] [Abstract][Full Text] [Related]
12. 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Chang H; Qi X; Jiang A; Xu W; Young T; Reece D
Bone Marrow Transplant; 2010 Jan; 45(1):117-21. PubMed ID: 19448682
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy and multiple myeloma: incidence of chromosomal aneuploidy detected by interphase fluorescence in situ hybridization.
Cianciulli AM; Coletta AM; Pescatore B; Greco C; Del Monte G; Leonardo C; Venturo I; Gandolfo GM
Eur J Histochem; 1997; 41 Suppl 2():157-8. PubMed ID: 9859828
[No Abstract] [Full Text] [Related]
14. DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.
Leo E; Kropff M; Lindemann A; Steinfurth G; Esselborn H; Rossner R; Adler CP; Böcking A
Anal Quant Cytol Histol; 1995 Apr; 17(2):113-20. PubMed ID: 7612131
[TBL] [Abstract][Full Text] [Related]
15. Random aneuploidy in neoplastic and pre-neoplastic diseases, multiple myeloma, and monoclonal gammopathy.
Amiel A; Gronich N; Yukla M; Suliman S; Josef G; Gaber E; Drori G; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2005 Oct; 162(1):78-81. PubMed ID: 16157205
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
[TBL] [Abstract][Full Text] [Related]
17. Centrosome amplification as a possible marker of mitotic disruptions and cellular carcinogenesis in multiple myeloma.
Dementyeva E; Nemec P; Kryukov F; Muthu Raja KR; Smetana J; Zaoralova R; Greslikova H; Kupska R; Kuglik P; Hajek R
Leuk Res; 2010 Aug; 34(8):1007-11. PubMed ID: 20096458
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance.
Bernasconi P; Cavigliano PM; Boni M; Astori C; Calatroni S; Giardini I; Rocca B; Caresana M; Crosetto N; Lazzarino M; Bernasconi C
Br J Haematol; 2002 Aug; 118(2):545-9. PubMed ID: 12139743
[TBL] [Abstract][Full Text] [Related]
19. Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
Chang H; Yeung J; Xu W; Ning Y; Patterson B
Br J Haematol; 2006 Sep; 134(6):613-5. PubMed ID: 16889615
[TBL] [Abstract][Full Text] [Related]
20. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]